The global Blood Collection Devices Market, valued at US$8.61 billion in 2024, stood at US$9.13 billion in 2025 and is ...
The panels employ PCR techniques to test for numerous gastrointestinal bacterial pathogens using one stool swab.
BD (NYSE: BDX) today announced that it completed enrollment in the iliac artery patient cohort in its pivotal AGILITY study.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback